Literature DB >> 31270232

Immune-Mediated Control of a Dormant Neurotropic RNA Virus Infection.

Katelyn D Miller1,2, Christine M Matullo2, Katelynn A Milora1, Riley M Williams2, Kevin J O'Regan2, Glenn F Rall3,2.   

Abstract

Genomic material from many neurotropic RNA viruses (e.g., measles virus [MV], West Nile virus [WNV], Sindbis virus [SV], rabies virus [RV], and influenza A virus [IAV]) remains detectable in the mouse brain parenchyma long after resolution of the acute infection. The presence of these RNAs in the absence of overt central nervous system (CNS) disease has led to the suggestion that they are viral remnants, with little or no potential to reactivate. Here we show that MV RNA remains detectable in permissive mouse neurons long after challenge with MV and, moreover, that immunosuppression can cause RNA and protein synthesis to rebound, triggering neuropathogenesis months after acute viral control. Robust recrudescence of viral transcription and protein synthesis occurs after experimental depletion of cells of the adaptive immune response and is associated with a loss of T resident memory (Trm) lymphocytes within the brain. The disease associated with loss of immune control is distinct from that seen during the acute infection: immune cell-depleted, long-term-infected mice display severe gait and motor problems, in contrast to the wasting and lethal disease that occur during acute infection of immunodeficient hosts. These results illuminate the potential consequences of noncytolytic, immune-mediated viral control in the CNS and demonstrate that what were once considered "resolved" RNA viral infections may, in fact, induce diseases later in life that are distinct from those caused by acute infection.IMPORTANCE Viral infections of neurons are often not cytopathic; thus, once-infected neurons survive, and viral RNAs can be detected long after apparent viral control. These RNAs are generally considered viral fossils, unlikely to contribute to central nervous system (CNS) disease. Using a mouse model of measles virus (MV) neuronal infection, we show that MV RNA is maintained in the CNS of infected mice long after acute control and in the absence of overt disease. Viral replication is suppressed by the adaptive immune response; when these immune cells are depleted, viral protein synthesis recurs, inducing a CNS disease that is distinct from that observed during acute infection. The studies presented here provide the basis for understanding how persistent RNA infections in the CNS are controlled by the host immune response, as well as the pathogenic consequences of noncytolytic viral control.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  RNA virus; T resident memory cells; central nervous system; measles virus; neuron; viral persistence

Mesh:

Substances:

Year:  2019        PMID: 31270232      PMCID: PMC6714802          DOI: 10.1128/JVI.00241-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

Review 1.  A triple entente: virus, neurons, and CD8+ T cells maintain HSV-1 latency.

Authors:  Sherrie Divito; Thomas L Cherpes; Robert L Hendricks
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

2.  Immune-mediated protection from measles virus-induced central nervous system disease is noncytolytic and gamma interferon dependent.

Authors:  Catherine E Patterson; Diane M P Lawrence; Lisa A Echols; Glenn F Rall
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

3.  Persistence of viral RNA in the brain of offspring to mice infected with influenza A/WSN/33 virus during pregnancy.

Authors:  Fredrik Aronsson; Charlotta Lannebo; Martin Paucar; Johan Brask; Krister Kristensson; Håkan Karlsson
Journal:  J Neurovirol       Date:  2002-08       Impact factor: 2.643

4.  Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons.

Authors:  T Liu; K M Khanna; B N Carriere; R L Hendricks
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

5.  Persistence of viral RNA in mouse brains after recovery from acute alphavirus encephalitis.

Authors:  B Levine; D E Griffin
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

6.  Viral studies in the cerebrospinal fluid in subacute sclerosing panencephalitis.

Authors:  Banu Anlar; Ahmet Pinar; F Yaşar Anlar; Doruk Engin; Semsettin Ustaçelebi; Tanil Kocagöz; Dürdal Us; Deniz Akduman; Kalbiye Yalaz
Journal:  J Infect       Date:  2002-04       Impact factor: 6.072

7.  Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response.

Authors:  Diethilde Theil; Tobias Derfuss; Igor Paripovic; Simone Herberger; Edgar Meinl; Olaf Schueler; Michael Strupp; Viktor Arbusow; Thomas Brandt
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

8.  Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia.

Authors:  Kamal M Khanna; Robert H Bonneau; Paul R Kinchington; Robert L Hendricks
Journal:  Immunity       Date:  2003-05       Impact factor: 31.745

9.  CD4 T cell control primary measles virus infection of the CNS: regulation is dependent on combined activity with either CD8 T cells or with B cells: CD4, CD8 or B cells alone are ineffective.

Authors:  Antoinette Tishon; Hanna Lewicki; Abegail Andaya; Dorian McGavern; Lee Martin; Michael B A Oldstone
Journal:  Virology       Date:  2006-03-10       Impact factor: 3.616

10.  CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons.

Authors:  T Liu; K M Khanna; X Chen; D J Fink; R L Hendricks
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307

View more
  7 in total

1.  Why does viral RNA sometimes persist after recovery from acute infections?

Authors:  Diane E Griffin
Journal:  PLoS Biol       Date:  2022-06-01       Impact factor: 9.593

2.  Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer's Disease.

Authors:  Tamàs Fülöp; Usma Munawara; Anis Larbi; Mathieu Desroches; Serafim Rodrigues; Michele Catanzaro; Andrea Guidolin; Abdelouahed Khalil; François Bernier; Annelise E Barron; Katsuiku Hirokawa; Pascale B Beauregard; David Dumoulin; Jean-Philippe Bellenger; Jacek M Witkowski; Eric Frost
Journal:  CNS Drugs       Date:  2020-07       Impact factor: 6.497

3.  Injection with Toxoplasma gondii protein affects neuron health and survival.

Authors:  Oscar A Mendez; Emiliano Flores Machado; Jing Lu; Anita Koshy
Journal:  Elife       Date:  2021-06-09       Impact factor: 8.140

Review 4.  Coronavirus persistence in human respiratory tract and cell culture: An overview.

Authors:  Adriana Gaspar-Rodríguez; Ana Padilla-González; Evelyn Rivera-Toledo
Journal:  Braz J Infect Dis       Date:  2021-10-02       Impact factor: 3.257

Review 5.  Multiple Receptors Involved in Invasion and Neuropathogenicity of Canine Distemper Virus: A Review.

Authors:  Jianjun Zhao; Yanrong Ren
Journal:  Viruses       Date:  2022-07-12       Impact factor: 5.818

Review 6.  Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms.

Authors:  Amy D Proal; Michael B VanElzakker
Journal:  Front Microbiol       Date:  2021-06-23       Impact factor: 5.640

Review 7.  Live Viral Vaccine Neurovirulence Screening: Current and Future Models.

Authors:  Corey May Fulton; Wendy J Bailey
Journal:  Vaccines (Basel)       Date:  2021-06-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.